Clinical Trial Update: Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell Carcinoma [Phase 2]

View source ↗

Summary

This update notes a Phase 2 clinical trial investigating the combination of tivozanib and nivolumab in advanced non-clear cell renal cell carcinoma, currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-clear Cell Renal Cell Carcinoma
• Renal Cell Carcinoma

Drugs mentioned

• Tivozanib (tivozanib)
• nivolumab (nivolumab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Renal Cell Carcinoma | Phase 2 | Status: RECRUITING